← Browse by Condition
Medical Condition
sepsis
Total Trials
27
Recruiting Now
27
Trial Phases
Phase 4, Phase 3, Phase 1
NCT07040202
Recruiting
Immune Responses to Dengue and Sepsis
Enrollment
240 pts
Location
Cambodia
Sponsor
Institut Pasteur du Cambodge
NCT02979951
Recruiting
Fosfomycin I.v. for Treatment of Severely Infected Patients
Enrollment
1,000 pts
Location
Austria, Germany, Gr...
Sponsor
Infectopharm Arzneimittel GmbH
NCT06694181
Recruiting
Safe and Explainable AI
Enrollment
300,000 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn...
NCT07230067
Recruiting
Sepsis-associated Thrombocytopenia and Platelet Transfusion (STAPT)
Enrollment
1,500 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
NCT04130789
Recruiting
Personalized Swiss Sepsis Study
Enrollment
17,500 pts
Location
Switzerland
Sponsor
University Hospital, Basel, Sw...
NCT06368388
Recruiting
Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force
Enrollment
50 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
NCT07448805
Recruiting
Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit
Enrollment
100 pts
Location
Slovenia
Sponsor
University Medical Centre Mari...
NCT07172451 Phase 4
Recruiting
Gelaspan vs Crystalloid Therapy in Sepsis
Enrollment
318 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
NCT05770622 Phase 4
Recruiting
Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)
Enrollment
40 pts
Location
Australia
Sponsor
Murdoch Childrens Research Ins...
NCT05565222 Phase 3
Recruiting
Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit
Enrollment
600 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT05453695 Phase 1
Recruiting
Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)
Enrollment
36 pts
Location
Canada
Sponsor
McMaster University
NCT05634057
Recruiting
Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis
Enrollment
782 pts
Location
China
Sponsor
Chen Ying
NCT07287332
Recruiting
BLOOM: Pragmatic Feasibility Trial
Enrollment
300 pts
Location
United States
Sponsor
Mayo Clinic
NCT07060560
Recruiting
Presepsin Diagnostic Performance in Severe Burn Sepsis
Enrollment
138 pts
Location
South Korea
Sponsor
Dohern Kym
NCT02707497 Phase 2, Phase 3
Recruiting
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia
Enrollment
200 pts
Location
China
Sponsor
Ruilan Wang
NCT06178822
Recruiting
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Enrollment
3,300 pts
Location
Netherlands
Sponsor
Amsterdam University Medical C...
NCT07084129 Phase 1
Recruiting
Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention
Enrollment
20 pts
Location
United States
Sponsor
Children's Hospital of Philade...
NCT06476171
Recruiting
Validation of Hematological Indices
Enrollment
200 pts
Location
Russia
Sponsor
Petrovsky National Research Ce...
NCT06624436 Phase 4
Recruiting
Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
Enrollment
52 pts
Location
Netherlands
Sponsor
Radboud University Medical Cen...
NCT05758246 Phase 2
Recruiting
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
Enrollment
220 pts
Location
United States
Sponsor
University of Minnesota
NCT06116656
Recruiting
Changes in Host Gene Expression to Differentiate Between Systemic Inflammation and Infection After Major Surgery
Enrollment
150 pts
Location
Netherlands
Sponsor
St. Antonius Hospital
NCT05623722
Recruiting
Erector Spinae Plane Block Improves Organ Dysfunction in Septic Patients With Acute Gastrointestinal Injury
Enrollment
116 pts
Location
China
Sponsor
Jing Cai, MD
NCT05304221
Recruiting
A Prospective Cluster-Randomized, Controlled Crossover Trial to Validate an Electronic "Resistance Calculator"
Enrollment
1,500 pts
Location
Israel
Sponsor
Dror MarChaim, MD
NCT05634733
Recruiting
Change in MAPSE During Treatment of Sepsis
Enrollment
50 pts
Location
United States
Sponsor
University of Maryland, Baltim...
NCT06219135
Recruiting
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis
Enrollment
1,372 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT06184659 Phase 4
Recruiting
Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis
Enrollment
5,800 pts
Location
Denmark
Sponsor
Scandinavian Critical Care Tri...
NCT06824350
Recruiting
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
Enrollment
45,450 pts
Location
United States, Kenya
Sponsor
University of California, Berk...